Connect Biopharma Holdings Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +535.1% | +1.2% | +0.0% | -5.3% | -16.0% | -8.5% | -10.7% | -18.6% | -16.8% | +7.1% | -27.6% | |
| – | +536.4% | +1.4% | +0.0% | -5.4% | -16.3% | -9.5% | -11.4% | -19.5% | -18.6% | +8.0% | -29.8% | |
| – | +844.2% | -0.3% | +0.0% | +4.3% | -29.0% | -39.0% | -14.8% | -6.9% | +1.3% | +20.1% | -41.3% | |
| – | +555.8% | – | – | -6.9% | -14.9% | – | – | – | – | – | – | |
| – | – | – | – | +996.3% | -72.7% | -99.2% | +2,312.5% | -91.2% | +847.1% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +595.9% | +0.1% | +0.0% | -8.1% | -7.0% | – | – | – | – | – | – | |
| – | +1,071.7% | +4.2% | +0.0% | -61.0% | -9.6% | +7.3% | +16.3% | +5.3% | +17.6% | +23.8% | -4.8% | |
| – | +1,081.3% | +4.3% | +0.0% | -61.9% | -12.1% | +1.2% | +25.4% | +6.4% | +19.1% | +25.2% | -4.4% | |
| – | +663.0% | – | – | -11.6% | -38.9% | – | – | – | – | – | – | |
| – | +383.3% | -71.1% | +0.0% | +158.1% | -94.0% | +138.9% | +180.8% | -13.1% | -1.5% | +119.2% | -53.2% | |
| – | +470.8% | +0.5% | +0.0% | +8.8% | -16.6% | -10.1% | -13.9% | -22.4% | -24.2% | +1.5% | -37.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.0% | -0.1% | +0.9% | -0.7% | +0.3% | +0.3% | +0.5% | -0.2% | +12.7% | +0.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.